Unibest
← Back to patent-cliff list

CAS 61079-72-9

2,3,4-trifluorobenzoic acid

Codes: COBI-012, SELT-001, BINI-001

Application context (from source-drug indications)

MelanomaCobimetinib FumaratePlexiform neurofibromaSelumetinib sulfateNeurofibromatosis type ISelumetinib sulfateNon-small cell lung cancerBinimetinibMelanomaBinimetinibColorectal cancerBinimetinibHairy cell leukaemiaBinimetinibPlexiform neurofibromaBinimetinibNeurofibromatosis type IBinimetinib

Source drugs (routes using this intermediate)

DrugTierExpiry
Cobimetinib FumarateTier C — Watch / trade2029
Selumetinib sulfateTier C — Watch / trade2032
BinimetinibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.